Dr. Bo Xu is President of National Society of Artificial Intelligence in Oncology, China Anti-Cancer Association（CACA). Before joining TMUCIH, he had been Distinguished Fellow and Chairman of Oncology Department at Southern Research Institute (SRI) and Professor of Pathology at University of Alabama at Birmingham (UAB) in the United States, where he headed the long-standing cancer research program at SRI. Currently he also serves on the Board of Directors of CACA , an oversea fellow the Royal Society of Medicine of UK, and the editorial board of Radiotherapy and Oncology (the Green Journal) and the Biomedical Journal.
Dr. Xu received Ph.D. degree (1998) in Radiation Oncology from the Peking Union Medical College and he completed his postdoctoral training at St. Jude Children’s Research Hospital in Memphis, TN. In 2002, Dr. Xu started a faculty position at the LSU Health Sciences Center in New Orleans, serving as tenure tracked Assistant Professor in the Department of Genetics. He joined SRI in 2006 as Associate Professor and Head of the Molecular Radiobiology Laboratory. Between 2009-2012, he had served as Professor and Director of Molecular Radiation Oncology in The Houston Methodist Hospital, Weill Cornell Medical College of Cornell University.
Dr. Xu’s major research interest is on molecular mechanisms of the DNA damage response. He has published more than 70 peer-review papers in major biomedical journals (including Nature, Cell, Molecular Cell), with more than 7500 citations. Six of his papers have been recommended by Faculty 1000.